Differences in Initial Benign Prostatic Hyperplasia Management Between Primary Care Physicians and Urologists-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Differences in Initial Benign Prostatic Hyperplasia Management Between Primary Care Physicians and Urologists

Published:2009-11 Issue:5 Volume:182 Page:2410-2414
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Hollingsworth John M.¹,Hollenbeck Brent K.¹²,Daignault Stephanie³,Kim Simon P.¹,Wei John T.¹

Affiliation:

1. Department of Urology, Division of Health Services Research, University of Michigan, Ann Arbor, Michigan

2. Michigan Surgical Collaborative for Outcomes Research and Evaluation, Ann Arbor, Michigan

3. Biostatistics Unit, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference19 articles.

1. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia;Lepor;N Engl J Med,1996

2. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia;McConnell;N Engl J Med,1998

3. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia;McConnell;N Engl J Med,2003

4. Urologic Diseases in America Project: benign prostatic hyperplasia;Wei;J Urol,2005

5. Differences between generalist and specialist physicians regarding Helicobacter pylori and peptic ulcer disease;Fendrick;Am J Gastroenterol,1996

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. UK national bladder outlet obstruction surgery snapshot audit;BJU International;2021-10-28

2. Tamsulosin dispensation patterns in the United States: a real-world, longitudinal, population claims database analysis;Translational Andrology and Urology;2019-08

3. Patient-reported Goal Achievement after Treating Male Benign Prostatic Hyperplasia with Alpha-adrenergic Antagonist: A-12week Prospective Multicenter Study;UROL J;2019

4. Alpha Blocker and 5-Alpha Reductase Inhibitor Prescribing Habits among Urologists and Primary Care Physicians;Urology Practice;2019-07

5. Potential Savings in Medicare Part D for Common Urological Conditions;Urology Practice;2018-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3